Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis

Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis

Aim. To study the link of increased serum concentrations of osteoprotegerin (OPG) in patients with chronic heart failure (CHF) associated with type 2 diabetes mellitus (DM 2), osteoporosis or osteopenia with the development of cardiovascular events (primarily, decompensation of CHF, including those...

Full description

Bibliographic Details
Main Authors: A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, A. A. Popova, I. V. Yakovleva, A. V. Molokov, E. V. Grakova, K. V. Kopeva, A. V. Svarovskaya, O. V. Garmaeva, Yu. Yu. Torim, E. I. Stepachev, V. V. Kalyuzhin
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2018-12-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
osteoprotegerin
risk factors
heart failure
diabetes
osteoporosis
prognosis
Online Access:https://bulletin.tomsk.ru/jour/article/view/1987

Internet

https://bulletin.tomsk.ru/jour/article/view/1987

Similar Items